These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25089763)

  • 1. Dual therapy difficulties in angiotensin blockade for proteinuria: a teachable moment.
    Hung KW; Blaine J; Faubel S
    JAMA Intern Med; 2014 Sep; 174(9):1429-30. PubMed ID: 25089763
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute renal failure during lisinopril and losartan therapy for proteinuria.
    Hanevold CD
    Pharmacotherapy; 2006 Sep; 26(9):1348-51. PubMed ID: 16945058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual renin-angiotensin system blockade at optimal doses for proteinuria.
    Laverman GD; Navis G; Henning RH; de Jong PE; de Zeeuw D
    Kidney Int; 2002 Sep; 62(3):1020-5. PubMed ID: 12164886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors.
    Seeman T; Pohl M; Misselwitz J; John U
    Kidney Blood Press Res; 2009; 32(6):440-4. PubMed ID: 20016211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are two better than one? Angiotensin-converting enzyme inhibitors plus angiotensin receptor blockers for reducing blood pressure and proteinuria in kidney disease.
    Linas SL
    Clin J Am Soc Nephrol; 2008 Jan; 3 Suppl 1(Suppl 1):S17-23. PubMed ID: 18178792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ; Stapff M; Lin Y
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of hyperkalemia in high risk patients during treatment with an angiotensin converting enzyme inhibitor (Lisinopril) versus an angiotensin II receptor blocker (Losartan).
    Zanabli AR; Yango A; Dworkin L
    S D J Med; 2004 Jun; 57(6):227-31. PubMed ID: 15253477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between the effects of lisinopril and losartan on the cougn reflex in anesthetized and awake rabbits.
    Mutolo D; Cinelli E; Bongianni F; Evangelista S; Pantaleo T
    J Physiol Pharmacol; 2013 Apr; 64(2):201-10. PubMed ID: 23756395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparison of losartan, lisinopril and hydrochlorothiazide in hypertensive patients with a previous angiotensin converting enzyme inhibitor-associated cough.
    Ramsay LE; Yeo WW;
    J Hypertens Suppl; 1995 Jul; 13(1):S73-6. PubMed ID: 18800460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline].
    Renke M; Rutkowski P; Tylicki L; Zietkiewicz M; Larczyński W; Rutkowski B
    Przegl Lek; 2008; 65(6):312-4. PubMed ID: 18853664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
    Renke M; Tylicki L; Rutkowski P; Wojnarowski K; Lysiak-Szydlowska W; Rutkowski B
    Scand J Urol Nephrol; 2005; 39(6):511-7. PubMed ID: 16303729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists].
    de Paz S; Martín AB; Iglesias A; Domínguez AR
    Med Clin (Barc); 1999 Dec; 113(19):759. PubMed ID: 10680137
    [No Abstract]   [Full Text] [Related]  

  • 13. The hazards of dual renin-angiotensin blockade in chronic kidney disease.
    Ku E; Park J; Vidhun J; Campese V
    Arch Intern Med; 2009 Jun; 169(11):1015-8. PubMed ID: 19506167
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antihypertensive drug therapy--combination of AT1-receptor blocker and betablocker].
    Schindler C; Kosa M; Schröder J; Kirch W
    Dtsch Med Wochenschr; 2010 May; 135(3):98. PubMed ID: 20077385
    [No Abstract]   [Full Text] [Related]  

  • 15. Losartan-induced cough after lisinopril therapy.
    Conigliaro RL; Gleason PP
    Am J Health Syst Pharm; 2000 May; 57(10):996-7. PubMed ID: 10832502
    [No Abstract]   [Full Text] [Related]  

  • 16. Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency.
    Hou FF; Xie D; Zhang X; Chen PY; Zhang WR; Liang M; Guo ZJ; Jiang JP
    J Am Soc Nephrol; 2007 Jun; 18(6):1889-98. PubMed ID: 17494885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin receptor blocker-induced visceral angioedema.
    Thalanayar MP; Fajt ML; Birnie KM; Ghobrial II; Petrov AA
    J Investig Allergol Clin Immunol; 2015; 25(1):63-4. PubMed ID: 25898699
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term antiproteinuric effect of dual renin-angiotensin system blockade.
    Robles NR; Fernandez Carbonero E; Romero B; Sánchez Casado E; Cubero JJ
    Cardiovasc Ther; 2009; 27(2):101-7. PubMed ID: 19426247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
    Renke M; Tylicki L; Rutkowski P; Rutkowski B
    Scand J Urol Nephrol; 2004; 38(5):427-33. PubMed ID: 15764256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.